CV Sciences (CVSI) Operating Margin Growth (5y) (2018 - 2026)
CV Sciences (CVSI) Operating Margin Growth (5y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.78 Bn | 87.91 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.91 Bn | 32.17 Bn | 1.97 Bn |
| 3 | Zoetis | 32.59 Bn | 30.65 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.54 Bn | 23.48 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.04 Bn | 20.89 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 21.48 Bn | 21.48 Bn | - |
| 7 | Viatris | 20.40 Bn | 18.60 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.80 Bn | 16.49 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.60 Bn | 12.17 Bn | 785.00 Mn |
| 10 | CV Sciences | 3.74 Mn | 3.43 Mn | 1.56 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5,431.00 |
| Dec 31, 2025 | 17,977.00 |
| Sep 30, 2025 | 4,819.00 |
| Jun 30, 2025 | 8,269.00 |
| Mar 31, 2025 | 6,463.00 |
| Dec 31, 2024 | 6,209.00 |
| Sep 30, 2024 | 525.00 |
| Jun 30, 2024 | -2,218.00 |
| Mar 31, 2024 | 4,740.00 |
| Dec 31, 2023 | -4,277.00 |
| Sep 30, 2023 | -3,661.00 |
| Jun 30, 2023 | -5,383.00 |
| Mar 31, 2023 | 13,063.00 |
| Dec 31, 2022 | -5,679.00 |
| Sep 30, 2022 | -1,516.00 |
| Jun 30, 2022 | -3,488.00 |
| Mar 31, 2022 | 6,300.00 |
| Dec 31, 2021 | 7,827.00 |
| Sep 30, 2021 | -462.00 |
| Jun 30, 2021 | 1,448.00 |